NASOPHARYNGEAL CARCINOMA (NPC)
Clinical trials for NASOPHARYNGEAL CARCINOMA (NPC) explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CARCINOMA (NPC) trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CARCINOMA (NPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to fight back when standard treatments fail for advanced head & neck cancer
Disease control Not yet recruitingThis study is testing whether a new combination of two immunotherapy drugs, scipibaimab and tislelizumab, can help control advanced nasopharyngeal cancer that has come back or spread after standard first-line treatments have stopped working. It will involve about 37 adults whose …
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New drug showdown: can it outperform standard pills to keep advanced throat cancer at bay?
Disease control Not yet recruitingThis study aims to see if a new intravenous drug, Becotatug Vedotin, works better than the standard oral chemotherapy (capecitabine) at preventing cancer from coming back in people with high-risk, advanced nasopharyngeal carcinoma (a type of throat cancer). It will involve about …
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Kai Hu • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Donor immune cells join fight against advanced throat cancer
Disease control Not yet recruitingThis trial is testing whether adding donor immune cells called Natural Killer (NK) cells to standard chemotherapy and radiation can reduce cancer recurrence in patients with advanced nasopharyngeal cancer. The study will first find the safest dose of these donor cells, then test …
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE1, PHASE2 • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
New drug tested to shield cancer patients from Chemotherapy's Blood-Thinning danger
Prevention Not yet recruitingThis study is testing whether a drug called hetrombopag can prevent a serious side effect of chemotherapy for nasopharyngeal (nose and throat) cancer. The side effect, called thrombocytopenia, is when platelet counts drop too low, raising the risk of dangerous bleeding. The study…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Prevention
Last updated Apr 01, 2026 23:26 UTC
-
Scientists probe Cancer's defenses to find new weaknesses
Knowledge-focused Not yet recruitingThis research aims to understand how nasopharyngeal cancer changes and resists immunotherapy over time. Researchers will analyze tumor tissue samples from 600 patients who have already received standard treatment. The goal is to identify specific biological markers that predict t…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC
-
New scans aim to predict cancer treatment success
Knowledge-focused Not yet recruitingThis study aims to see if two new types of PET/CT scans can help doctors more accurately stage nasopharyngeal cancer and predict how well a patient will respond to immunotherapy before they start treatment. It will involve about 732 adults with newly diagnosed cancer who have not…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC